文献速递银屑病与炎症性皮肤病

将世界卫生大会决议转化为成员国行动:德国针对可见慢性皮肤病患者去污名化项目

Translating the WHA resolution in a member state: towards a German programme on 'Destigmatization' for individuals with visible chronic skin diseases.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-07-08

研究基于世界卫生大会决议,由研究者、皮肤科医生和患者组成的专家联盟制定去污名化概念,并获得联邦卫生部2018-2020年三年项目资助,用于开发、实施和评估干预措施。

要点

  • 世卫组织决议推动成员国采取行动应对皮肤病污名化。
  • 德国专家联盟制定去污名化概念并获得卫生部三年资助。
  • 下一步将在污名化常发生的场景中测试干预措施。

核心结论

  • 世界卫生大会关于银屑病去污名化的呼吁被转化为德国政府支持的三年去污名化项目。

研究设计与样本

  • 通过向决策者、政治家和联邦卫生部发起一系列行动,基于卫生服务研究数据开展论证。
  • 由研究者、皮肤科医生和患者组成的专家联盟制定去污名化概念。

主要发现

  • 政治层面的活动在很大程度上成功获得联邦卫生部资助的2018-2020年三年项目。
  • 项目包括概念与开发、干预与评估、数据分析及长期概念制定。

临床怎么用

  • 通过皮肤科医生、研究者、患者和政策制定者的成功合作推动去污名化。
  • 下一步在污名化通常发生的场景中测试干预措施,数据用于实施长期概念。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Even today, a substantial number of individuals with visible skin diseases still suffer from incomprehension and stigmatization. About 10 million people are affected by such diseases in Germany. The WHO strongly urges member states to take measures against stigmatization in skin diseases. OBJECTIVES: Objectives are the development of an action programme to raise awareness and address stigmatization. Therefore, conception, development and testing of interventions for the destigmatization of persons with skin diseases in Germany will be carried out. METHODS: A series of actions addressing decision makers, politicians and the Federal Ministry of Health were initiated, all based on the World Health Assembly (WHA). Argumentation was largely based on data from health services research. Supported by the Federal Ministry of Health, a concept against stigmatization was developed by an expert consortium of researchers, dermatologists and patients. Specific strategies of structured destigmatization between those affected and those not will be developed and scientifically evaluated. RESULTS: The activities addressed to politics were - to a large extent - successfully and financially supported by a 3-year programme (2018-2020), designed to develop interventions against stigma. It was funded by the Federal Ministry of Health. The project includes conception and development, intervention and evaluation, data analyses and development of a long-term concept. CONCLUSIONS: The WHO's call against stigmatization in psoriasis (resolution WHA67.9 and global report on psoriasis 2016) was taken into account and developed into a destigmatization programme supported by the German government and German politicians. This has been achieved by successful collaborations between dermatologists, researchers, patients and policymakers. Next step will be the testing of interventions in situations and surroundings, where stigmatization usually occurs. The data will be used for the implementation of a long-term concept that can be used to continue destigmatization in Germany far beyond the project's initial phase.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Augustin M, Mrowietz U, Luck-Sikorski C, et al. Translating the WHA resolution in a member state: towards a German programme on 'Destigmatization' for individuals with visible chronic skin diseases. J Eur Acad Dermatol Venereol. 2019. PMID: 31087405. doi:10.1111/jdv.15682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。